11 February 2026
Microbiotica Announces Impressive Results in its Phase 1b Trial of MB310 in Ulcerative Colitis
Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), announces positive...